Burden of diabetic macular oedema in patients receiving antivascular endothelial growth factor therapy in South Korea: a healthcare resource use and cost analysis

OBJECTIVE: To examine healthcare resource utilisation (HRU) and direct medical costs for patients with diabetic macular oedema (DME) treated with antivascular endothelial growth factor (anti-VEGF) in Korea by comparing with those for (1) patients with diabetes mellitus (DM) without retinopathy and (...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Ha-Lim, Lee, Hyesung, Yoon, Dongwon, Lee, Yeonkyung, Kim, Jae Hui, Jee, Donghyun, Shin, Ju-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778761/
https://www.ncbi.nlm.nih.gov/pubmed/33376178
http://dx.doi.org/10.1136/bmjopen-2020-042484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778761/
https://www.ncbi.nlm.nih.gov/pubmed/33376178
http://dx.doi.org/10.1136/bmjopen-2020-042484

Ejemplares similares